Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Latest filing published 08 Mar 2024 for Adma Biologics, INC., €94k. Read the official filing
Filing timeline
BuySaleBrian Lenz
Insider track record
Disclosed buys
2
Disclosed sells
1
T+90 hit rate
50%
T+90 mean return
+1.0%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Brian Lenz: trading record in brief
All filings by Brian Lenz on record concern Adma Biologics, Inc., in the capacity of finance chief. We count 17 filings; the first trade dates from 29 September 2021 and the latest from 6 March 2024.
In open-market terms, that means 2 purchases worth €45k on one side and 1 sale worth €892k on the other. Netting one side against the other leaves €847k of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 14 share grants.
The newest entry dates from 8 March 2024: a share grant of €94k, in Adma Biologics, Inc. The clock since the last published purchase (9 December 2022) now reads 1,409 days. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Brian Lenz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
16,677 shares@ US$6.124.5% of flowCommon StockSEC:0001140361-24-012446:0
4,935 shares@ US$5.361.2% of flowCommon StockSEC:0001140361-24-011193:0
8,257 shares@ US$5.261.9% of flowCommon StockSEC:0001140361-24-009843:0
16,908 shares@ US$4.523.3% of flowCommon StockSEC:0001140361-24-001139:0
15,268 shares@ US$3.582.5% of flowCommon StockSEC:0001140361-23-046742:0
211,578 shares@ US$4.597543.2% of flowCommon StockSEC:0001140361-23-040321:0
15,268 shares@ US$3.692.5% of flowCommon StockSEC:0001140361-23-033191:0
15,469 shares@ US$3.312.3% of flowCommon StockSEC:0001140361-23-016460:0
1,559 shares@ US$3.420.2% of flowCommon StockSEC:0001140361-23-010773:0
114,222 shares@ US$3.8720.3% of flowCommon StockSEC:0001140361-23-000872:0
6,993 shares@ US$2.860.9% of flowCommon StockSEC:0001140361-22-045112:0
Canonical exit: 9 Mar 2023 (T+90)
73,678 shares@ US$2.438.8% of flowCommon StockSEC:0001140361-22-036163:0
51,965 shares@ US$1.433.5% of flowCommon StockSEC:0001140361-22-019216:0
37,178 shares@ US$1.462.4% of flowCommon StockSEC:0001140361-22-011251:0
137,500 shares0Common StockSEC:0001140361-22-008673:0
30,000 shares@ US$1.001.3% of flowCommon StockSEC:0001140361-21-035380:0
Canonical exit: 23 Jan 2022 (T+90)
495,000 shares0Common StockSEC:0001140361-21-033355:0
17 of 17 declarations
